Repetitive cycles of high-dose cytarabine are effective for childhood acute myeloid leukemia: long-term outcome of the children with AML treated on two consecutive trials of Tokyo Children's Cancer Study Group. (Q52013638)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Repetitive cycles of high-dose cytarabine are effective for childhood acute myeloid leukemia: long-term outcome of the children with AML treated on two consecutive trials of Tokyo Children's Cancer Study Group. |
scientific article |
Statements
1 reference
Repetitive cycles of high-dose cytarabine are effective for childhood acute myeloid leukemia: long-term outcome of the children with AML treated on two consecutive trials of Tokyo Children's Cancer Study Group. (English)
1 reference
1 reference
Ken Tabuchi
1 reference
Akitoshi Kinoshita
1 reference
Ryoji Hanada
1 reference
Hisato Kigasawa
1 reference
Ichiro Tsukimoto
1 reference
Masahiro Tsuchida
1 reference
Tokyo Children's Cancer Study Group
1 reference
1 August 2007
1 reference
49
1 reference
2
1 reference
127-132
1 reference
Identifiers
1 reference
1 reference